We just received data on a new analyst forecast for $REPL. HC Wainwright & Co. gave a rating of 'Neutral' for $REPL.
$REPL Analyst Ratings
Wall Street analysts have issued reports on $REPL in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 07/30/2025
- BMO Capital issued a "Underperform" rating on 07/23/2025
- Jefferies issued a "Buy" rating on 07/22/2025
- Piper Sandler issued a "Overweight" rating on 06/02/2025
To track analyst ratings and price targets for $REPL, check out Quiver Quantitative's $REPL forecast page.
$REPL Price Targets
Multiple analysts have issued price targets for $REPL recently. We have seen 8 analysts offer price targets for $REPL in the last 6 months, with a median target of $5.0.
Here are some recent targets:
- Evan David Seigerman from BMO Capital set a target price of $2.0 on 07/23/2025
- Peter Lawson from Barclays set a target price of $3.0 on 07/23/2025
- Robert Driscoll from Wedbush set a target price of $4.0 on 07/22/2025
- Anupam Rama from JP Morgan set a target price of $9.0 on 07/22/2025
- Roger Song from Jefferies set a target price of $6.0 on 07/22/2025
- Jonathan Chang from Leerink Partners set a target price of $3.0 on 07/22/2025
- Robert Burns from HC Wainwright & Co. set a target price of $22.0 on 07/03/2025
$REPL Insider Trading Activity
$REPL insiders have traded $REPL stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $REPL stock by insiders over the last 6 months:
- PHILIP ASTLEY-SPARKE sold 32,279 shares for an estimated $260,168
- SUSHIL PATEL (Chief Executive Officer) sold 25,105 shares for an estimated $202,346
- EMILY LUISA HILL (Chief Financial Officer) has made 0 purchases and 2 sales selling 11,689 shares for an estimated $69,563.
- KONSTANTINOS XYNOS (Chief Medical Officer) sold 7,952 shares for an estimated $64,093
- CHRISTOPHER SARCHI (Chief Commercial Officer) sold 3,749 shares for an estimated $30,179
- ANDREW SCHWENDENMAN (Chief Accounting Officer) sold 3,287 shares for an estimated $26,460
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$REPL Hedge Fund Activity
We have seen 86 institutional investors add shares of $REPL stock to their portfolio, and 95 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BRAIDWELL LP removed 1,038,939 shares (-71.1%) from their portfolio in Q2 2025, for an estimated $9,651,743
- SOFINNOVA INVESTMENTS, INC. removed 673,410 shares (-27.2%) from their portfolio in Q2 2025, for an estimated $6,255,978
- MARSHALL WACE, LLP removed 621,161 shares (-25.0%) from their portfolio in Q2 2025, for an estimated $5,770,585
- POINT72 ASSET MANAGEMENT, L.P. added 616,566 shares (+642.4%) to their portfolio in Q2 2025, for an estimated $5,727,898
- NUVEEN, LLC removed 544,084 shares (-81.0%) from their portfolio in Q2 2025, for an estimated $5,054,540
- ALLY BRIDGE GROUP (NY) LLC added 528,491 shares (+inf%) to their portfolio in Q2 2025, for an estimated $4,909,681
- NAN FUNG TRINITY (HK) LTD added 465,527 shares (+inf%) to their portfolio in Q2 2025, for an estimated $4,324,745
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
